Melanoma induces immunosuppression by up-regulating FOXP3+ regulatory T cells

被引:54
作者
Baumgartner, Joel
Wilson, Cara
Palmer, Brent
Richter, Don
Banerjee, Anirban
McCarter, Martin
机构
[1] Univ Colorado, Hlth Sci Ctr, Dept Surg, Denver, CO 80262 USA
[2] Univ Colorado, Dept Med, Div Immunol, Denver, CO USA
关键词
melanoma; regulatory T cells; FOXP3; cytokines; TUMOR-INFILTRATING LYMPHOCYTES; METASTATIC MELANOMA; PERIPHERAL-BLOOD; INCREASED POPULATIONS; PROGNOSTIC FACTORS; CANCER-PATIENTS; INTERLEUKIN-2; AUTOIMMUNITY; PREVALENCE; CARCINOMA;
D O I
10.1016/j.jss.2007.03.053
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. The immune response to melanoma is rarely curative, suggesting the emergence of immunosuppression. FOXP3-expressing regulatory T cells (T-reg cells) function to suppress immune responses. The objective of this study was to determine if melanoma evades immune surveillance, in part, by inducing T-reg cells. Material and methods. Peripheral blood mononuclear cells (PBMCs) were isolated and exposed to melanoma-conditioned media (MCM) or control media for 1 week. The induction of T-reg cells in these PBMCs was determined by measuring the proportion of CD25(+)FOXP3(+) T cells in all CD4(+) T cells by flow cytometry. FOXP3 expression was determined by mean fluorescence intensity (MFI) and Western blot. Supernatant cytokines were determined by ELISA. Results. Normal PBMCs exposed to MCM revealed higher proportions of T-reg cells than those exposed to control media after 6 days (3.4% versus 1.3%, respectively, P < 0.02). The expression of FOXP3 in T-reg cells from PBMCs exposed to MCM increased over time by MFI and Western blot but was not significantly different than those exposed to control media. The level of IL-10 and TGF-beta in supernatants after 6 days growth was higher in MCM than control media, but this did not reach statistical significance. Conclusion. Exposure of PBMCs to melanoma results in induction of FOXP3(+) T-reg cells. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:72 / 77
页数:6
相关论文
共 32 条
[1]   Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+CD25+ T cells [J].
Baecher-Allan, C ;
Wolf, E ;
Hafler, DA .
CLINICAL IMMUNOLOGY, 2005, 115 (01) :10-18
[2]   CD4+CD25high regulatory cells in human peripheral blood [J].
Baecher-Allan, C ;
Brown, JA ;
Freeman, GJ ;
Hafler, DA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1245-1253
[3]   Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma [J].
Cesana, GC ;
DeRaffele, G ;
Cohen, S ;
Moroziewicz, D ;
Mitcham, J ;
Stoutenburg, J ;
Cheung, K ;
Hesdorffer, C ;
Kim-Schulze, S ;
Kaufman, HL .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (07) :1169-1177
[4]   IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin [J].
Clark, Rachael A. ;
Kupper, Thomas S. .
BLOOD, 2007, 109 (01) :194-202
[5]   Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival [J].
Curiel, TJ ;
Coukos, G ;
Zou, LH ;
Alvarez, X ;
Cheng, P ;
Mottram, P ;
Evdemon-Hogan, M ;
Conejo-Garcia, JR ;
Zhang, L ;
Burow, M ;
Zhu, Y ;
Wei, S ;
Kryczek, I ;
Daniel, B ;
Gordon, A ;
Myers, L ;
Lackner, A ;
Disis, ML ;
Knutson, KL ;
Chen, LP ;
Zou, WP .
NATURE MEDICINE, 2004, 10 (09) :942-949
[6]   Ex vivo isolation and characterization of CD4+CD25+ T cells with regulatory properties from human blood [J].
Dieckmann, D ;
Plottner, H ;
Berchtold, S ;
Berger, T ;
Schuler, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (11) :1303-1310
[7]   Foxp3 Programs the Development and Function of CD4+CD25+ Regulatory T Cells (Reprinted from vol 4, pg 330-336, 2003) [J].
Fontenot, Jason D. ;
Gavin, Marc A. ;
Rudensky, Alexander Y. .
JOURNAL OF IMMUNOLOGY, 2017, 198 (03) :986-992
[8]  
Frumento Guido, 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P223, DOI 10.2174/187153006778250019
[9]   Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis [J].
Gambineri, E ;
Torgerson, TR ;
Ochs, HD .
CURRENT OPINION IN RHEUMATOLOGY, 2003, 15 (04) :430-435
[10]  
Gray CP, 2003, CLIN CANCER RES, V9, P2551